GlaxoSmithKline PLC ADR (GSK) Annual Income Statement (USD)
GSK Quarterly Financials (USD)
Frequently Asked Questions About GlaxoSmithKline PLC ADR (GSK) Stock
GlaxoSmithKline PLC ADR's (GSK) last reported annual revenue was USD 30.33 Billion.
GlaxoSmithKline PLC ADR's (GSK) annual revenue growth rate based on the revenue reported in the past 5 years is : -0.32%
GlaxoSmithKline PLC ADR's(GSK) is profitable as of its last reported annual financials.
The net profit margin for GlaxoSmithKline PLC ADR's(GSK) from its laster reported year is 16.25%
The return on equity (ROE) for GlaxoSmithKline PLC ADR's(GSK) from its last reported annual financials is : 46.38%
The return on assets (ROA) for GlaxoSmithKline PLC ADR's(GSK) from its last reported annual financials is : 8.30%
The return on invested capital (ROIC) for GlaxoSmithKline PLC ADR's(GSK) from its last reported annual financials is : 25.94%
The Debt to Equity ratio for GlaxoSmithKline PLC ADR's(GSK) from its last reported annual financials is : 0.00%
The dividend yield for GlaxoSmithKline PLC ADR's(GSK) from its laster reported year is 3.49%
GlaxoSmithKline PLC ADR's(GSK) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GSK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
